Dan provides trusted counsel and advocacy to health care clients on a variety of matters, such as corporate compliance, provider credentialing, administrative proceedings and litigation. He also advises clients on practice formation and acquisition, as well as contract review and preparation. In recent years, Dan has helped health care companies and providers navigate through fraud and abuse investigations, antitrust reviews, and other white collar criminal matters. He is a frequent author and lecturer on telehealth and telemedicine issues.
Prior to joining Dinsmore, Dan practiced for nearly seven years with the State Medical Board of Ohio, where he advised board members and agency personnel on issues related to the Medical Practices Act of Ohio, Chapter 119 Administrative Procedures, and federal rules and regulations implicating the area of health care. His substantial regulatory experience enables him to bring a unique and insightful perspective to handling diverse and complex health care matters, and his thorough understanding of health care laws and policies helps him serve as a valuable resource to corporations, health care associations, hospitals, medical practices and individual practitioners.
In addition to his experience with federal and state health care regulatory agencies, Dan has successfully aided clients appearing before a number of other administrative or executive entities, including the Ohio Department of Commerce, Accountancy Board of Ohio, and the Ohio Board of Registration for Professional Engineers and Surveyors. He previously served as an extern for the Legal Office of the Ohio governor, as well as the Business & Regulations Division of the Columbus city attorney’s office.
More Legal and Business Bylines From Daniel S. Zinsmaster
- “Up in Smoke?” President Biden Announces Pardons and Orders Review of Cannabis Classification - (Posted On Monday, October 24, 2022)
- Interstate License Compacts Arrive to Ohio for Physicians, Nurses, and Audiology/Speech-Language Pathologists - (Posted On Friday, July 16, 2021)
- FDA Continues to Referee the CBD Market - (Posted On Friday, April 02, 2021)
- X-Waiver Changes Axed: Federal Government Backtracks on Previously Announced Rescission of Waiver Requirements - (Posted On Monday, February 08, 2021)
- Interagency Fraud Enforcement Action Highlights Telepharmacy Compliance Risks - (Posted On Wednesday, February 03, 2021)
- Improper CBD Product Marketing Lands in FDA’s Crosshairs - (Posted On Tuesday, January 05, 2021)
- Ohio Pharmacist Duties to Report: Ohio Board Issues Updated Guidance - (Posted On Wednesday, December 02, 2020)
- Ohio Introduces Proposed Legislation to Expand Telehealth Services - (Posted On Thursday, October 08, 2020)
- Publications Ohio House Passes Bill to Protect Health Care Providers from Civil Liability and Professional Disciplinary Actions - (Posted On Thursday, June 04, 2020)
- Physicians Face Regulatory Exposure for Prescribing COVID-19 Drugs Cited by President Trump - (Posted On Thursday, April 09, 2020)
Daniel S. Zinsmaster is a Partner working in Dinsmore & Shohl’s health care practice. He was honored as an National Law Review Go-To Thought leader for his contributions to Ohio's decriminalization of hemp and hemp products and amendments to Ohio’s medical marijuana laws. His articles on the changing landscape of healthcare, especially as it relates to these controversial marijuana-based issues, help clarify a host of complicated changes in legislation and interpretation for National Law Review readers.